Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Index values are published at set times by providers, aiding timely decision-making. This intro explains publication schedules and access methods.
19,766 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Netflix is pivoting toward ads and international growth. This article breaks down the netflix's revenue expected surg...
As mdxhealth (MDXH) 2025 earnings unfold, investors watch cash burn, pipeline progress, and strategic partnerships. T...
Analysts are warming to a pair of fintech names as valuations cool and growth metrics improve. This report explains w...
When an executive at Century Aluminum sells millions in stock, investors take notice. This article breaks down what t...
Palantir’s latest quarter reported strong numbers and rising defense-related AI demand, boosting the stock and signal...
EOSE stock has surged in a volatile stretch as investors weigh grid-scale storage growth against project risks. This ...
A deep dive into MiB: Bill Gurley, Benchmark—how a pioneering VC built a team culture, backed Uber and other giants, ...
Nvidia’s leadership signals a pivotal moment in AI. This guide breaks down what the agentic inflection point means fo...
A 6% weekly pullback can feel painful, but for patient buyers, this growth stock march story is about resilience, rev...
Hims Hers Health shares jumped after news of a Novo Nordisk collaboration. This guide breaks down what the deal could...
Solmate plans a reverse stock split to fund a Solana-focused hub in the UAE, part of a broader pivot that includes ex...